Skip to content

Evaluation of bone marrow blood transplanted to lunate in Kienbock disease

Evaluation of bone marrow blood transplanted to lunate in Kienbock disease - BMB transplantation for Kienbock disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000010275
Enrollment
20
Registered
2013-04-01
Start date
2008-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kienbock disease

Interventions

None listed

Sponsors

Yuki HARA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: kienbokk disease patients who undergo BMC transplantation

Exclusion criteria

Exclusion criteria: not agree

Design outcomes

Primary

MeasureTime frame
cell count of inspirated BMB colony forming unit number after cell culture, CD34 count, Clinical outcome

Secondary

MeasureTime frame
Clinical outcome

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026